RxDoctor Payments DataLook up a doctor →

Aristides Maniatis

Pediatric Endocrinology · Centennial, CONPI 1316045701

Payments from drug & device makers

$3,050,013in general payments, 2019–2025

Across 2,078 payments — averaging $1467.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ascendis Pharma Endocrinology Inc$1.5M
  • Pfizer$751K
  • Novo Nordisk AS$278K
  • OPKO Pharmaceuticals, LLC$121K
  • Novo Nordisk$115K
  • AstraZeneca$114K
  • plus $135K from 33 others
$12,100in research payments, 2019–2025

Across 16 payments — averaging $756.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$12K

What the payments were for

  • Consulting fees$126,41619%
  • Speaking & faculty fees$423,77765%
  • Travel & lodging$87,06213%
  • Food & beverage$17,0483%
  • Education$6320%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,050,013 in reported general payments places this provider in the 95th percentile of 34 pediatric endocrinology providers in Colorado.

See all pediatric endocrinology providers in Colorado

Other pediatric endocrinology in Centennial

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →